ADAM10 and Alzheimer disease: Compared to subtype 1 and the normal subgroup, the expressions of MAPT, ADAM10, BACE1, and PSEN2 in subtype 2 resided in an intermediate state, which implied that subtype 2 might be a transition state from normal to AD.